167 related articles for article (PubMed ID: 21908735)
1. Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells.
Neunkirchner A; Leb-Reichl VM; Schmetterer KG; Mutschlechner S; Kueng HJ; Haiderer D; Schuch K; Wallner M; Jahn-Schmid B; Bohle B; Pickl WF
J Immunol; 2011 Oct; 187(8):4077-87. PubMed ID: 21908735
[TBL] [Abstract][Full Text] [Related]
2. Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner.
Schmetterer KG; Haiderer D; Leb-Reichl VM; Neunkirchner A; Jahn-Schmid B; Küng HJ; Schuch K; Steinberger P; Bohle B; Pickl WF
J Allergy Clin Immunol; 2011 Jan; 127(1):238-45, 245.e1-3. PubMed ID: 21211658
[TBL] [Abstract][Full Text] [Related]
3. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
[TBL] [Abstract][Full Text] [Related]
4. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
5. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
[TBL] [Abstract][Full Text] [Related]
6. Bet v 1 and its homologous food allergen Api g 1 stimulate dendritic cells from birch pollen-allergic individuals to induce different Th-cell polarization.
Smole U; Wagner S; Balazs N; Radauer C; Bublin M; Allmaier G; Hoffmann-Sommergruber K; Breiteneder H
Allergy; 2010 Nov; 65(11):1388-96. PubMed ID: 20557297
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes.
Leb VM; Jahn-Schmid B; Schmetterer KG; Kueng HJ; Haiderer D; Neunkirchner A; Fischer GF; Nissler K; Hartl A; Thalhamer J; Bohle B; Seed B; Pickl WF
J Allergy Clin Immunol; 2008 Jan; 121(1):64-71. PubMed ID: 18037161
[TBL] [Abstract][Full Text] [Related]
8. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
9. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses.
Wambre E; Bonvalet M; Bodo VB; Maillère B; Leclert G; Moussu H; Von Hofe E; Louise A; Balazuc AM; Ebo D; Hoarau C; Garcia G; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2011 Feb; 41(2):192-203. PubMed ID: 21105918
[TBL] [Abstract][Full Text] [Related]
10. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.
Bohle B; Breitwieser A; Zwölfer B; Jahn-Schmid B; Sára M; Sleytr UB; Ebner C
J Immunol; 2004 Jun; 172(11):6642-8. PubMed ID: 15153479
[TBL] [Abstract][Full Text] [Related]
12. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
13. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
14. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.
Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797
[TBL] [Abstract][Full Text] [Related]
15. A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions.
Polak D; Hafner C; Briza P; Kitzmüller C; Elbe-Bürger A; Samadi N; Gschwandtner M; Pfützner W; Zlabinger GJ; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2019 Mar; 143(3):1143-1152.e4. PubMed ID: 29920351
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells.
Gerstmayr M; Ilk N; Schabussova I; Jahn-Schmid B; Egelseer EM; Sleytr UB; Ebner C; Bohle B
J Immunol; 2007 Dec; 179(11):7270-5. PubMed ID: 18025169
[TBL] [Abstract][Full Text] [Related]
17. T cells specific to multiple Bet v 1 peptides are highly cross-reactive toward the corresponding peptides from the homologous group of tree pollens.
Lund G; Christensen LH; Ihlemann J; Andersen PS; Wambre E; Würtzen PA; Gupta S
Front Immunol; 2023; 14():1291666. PubMed ID: 38077382
[TBL] [Abstract][Full Text] [Related]
18. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.
Fritsch R; Bohle B; Vollmann U; Wiedermann U; Jahn-Schmid B; Krebitz M; Breiteneder H; Kraft D; Ebner C
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):679-86. PubMed ID: 9802379
[TBL] [Abstract][Full Text] [Related]
19. Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1.
Kitzmüller C; Nagl B; Deifl S; Walterskirchen C; Jahn-Schmid B; Zlabinger GJ; Bohle B
Allergy; 2012 May; 67(5):593-600. PubMed ID: 22188598
[TBL] [Abstract][Full Text] [Related]
20. Identification of Sola l 4 as Bet v 1 homologous pathogenesis related-10 allergen in tomato fruits.
Wangorsch A; Jamin A; Foetisch K; Malczyk A; Reuter A; Vierecke S; Schülke S; Bartel D; Mahler V; Lidholm J; Vieths S; Scheurer S
Mol Nutr Food Res; 2015 Mar; 59(3):582-92. PubMed ID: 24510486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
